Geratherm Medical Announces Preliminary Financial Figures for 2011
- Sales volume EUR 17.4 million +2.2 %
- EBITDA EUR 2.627 million -10.9 %
- EBITDA margin 15.1 % (2010: 17.4 %)
- EBIT EUR 2 million -17.1 %
- Financial result +126 kEUR (2010: +983 kEUR).
- Results from ordinary activities EUR 2.074 million (2010: EUR 3.334 million).
- Shareholder earnings (EAT) EUR 1.567 million (2010: EUR 2.712 million).
- Earnings per share 32 EUR cent (2010: 56 EUR cents)
- Proposed dividend 30 EUR cent per share
Geratherm Medical has posted a sales volume of EUR 17.4 million for 2011 and thus concluded the year with an operating result (EBIT) of EUR 1.948 million. Business development was impacted by the mild weather conditions that prevailed during the 4th quarter of 2012, the construction of a production facility in Brazil and the new business segments Respiratory and Cardio/Stroke. Without these factors, the operating result for 2011 would have been higher by 486 kEUR. While the financial result is positive with 126 kEUR, it is notably lower than in the previous year. The temporary depreciation of securities held as at 31 December 2011 had an unfavorable effect.
Claiming the existing loss carry-forwards on the basis of the good separate financial statements (HGB) results in an increased burden due to deferred taxes in the amount of 589 kEUR based on IFRS. These have no cash effect, however. By deducting these deferred taxes, a positive result for the shareholders of the parent company in the amount of EUR 1.567 million or 32 EUR cent per share was reported.
Because the dividend in the amount of 30 cents is paid entirely from the investment account (Einlagekonto per German Corporate Tax Law (KStG) §27), which does not include investments credited to the nominal share capital, it is paid without the deduction of capital gains tax and solidarity surtax. For domestic shareholders, the dividend is generally not subject to taxation.
The preliminary figures are subject to confirmation by the auditors and the approval of the supervisory board.
The final figures for the 2011 fiscal year and the annual report will be published on 24 April 2012.
Geratherm Medical AG
Geratherm Medical is an internationally operating medical products enterprise with the business areas 'Temperature Management', 'Cardio' and 'Respiratory'.
Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function.
In all three business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a researchbased medical products company with a clear focus on medical diagnostic devices that generate vital data.
Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Health-Care Index.